• The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.

  • Its acquiring biotech firms Curevo, LimmaTech Biologics, and the Vaccine Company,

  • Shares edged higher shortly after the opening bell.

https://www.cnbc.com/2026/05/26/eli-lilly-stock-vaccine-deals-curevo-limmatech.html